Home › Glioblastoma › North Carolina › Durham

Pag-aaral pangklinika para sa Glioblastoma sa Durham, NC

Isang pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Nagre-recruitPhase 3

University of North Carolina, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05902169

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Duke University Health System, Durham

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Duke University Health System, Durham

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

Duke Cancer Institute, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Nagre-recruitPhase 1

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT04903795

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Nagre-recruitPhase 2

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06319027

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

Nagre-recruitPhase 2

Duke University, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT05708352

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

Nagre-recruitPhase 2

Duke University, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06069726

Lerapolturev (PVSRIPO) in GBM

Nagre-recruitPhase 2

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06177964

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Nagre-recruitPhase 2

UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06805305

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Duke University Health System, Durham

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Nagre-recruitPhase 1

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT04547777

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Duke University Health System, Durham

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Nagre-recruitPhase 1

Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT05366179

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

Nagre-recruitObservasyonal na pag-aaral

Duke University, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06625684

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

D2C7-IT + 2141-V11 Combination Post-resection in rGBM

Nagre-recruitPhase 1

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2025 · NCT06455605

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Nagre-recruitPhase 1/2

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2025 · NCT05734560

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Nagre-recruitPhase 2

University of North Carolina, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 27, 2025 · NCT03175224

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Nagre-recruitPhase 1

Duke University, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2025 · NCT05879367

Pag-aaral para sa Glioblastoma sa ibang lungsod

Iba pang pag-aaral sa Durham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.